Genzyme Corp. sells off its diagnostics business to Sekisui Chemical Co. Ltd. for $265 million in cash. Genzyme Corp. (NSDQ:GENZ) is planning to sell off its diagnostics business to Tokyo-based ...

How do you whittle 35 years of headlining business news down to a couple thousand words and a few pages? You don't. But here, we take our best shot to highlight the companies, individuals, and moments ...

Sanofi-aventis CEO Chris Viebacher outlined the research and development strategy that led to the <a target="_blank" href="http://www.masshightech.com/stories/2011/02 ...

BOSTON (CBS.MW) -- Genzyme Corp. swung to a third-quarter net loss because of acquisition charges, but sales soared 60 percent on growth of a key kidney dialysis medication, the biotech firm reported ...

Genzyme Corp. has extended its lease for 45,161 square feet at The Richards Building at MIT’s University Park development in Cambridge, according to people familiar with the deal. Genzyme Corp. has ...

On April 5, 2022, MediciNova, Inc. MNOV filed a Form 8-K stating that Genzyme Corp., a subsidiary of Sanofi, filed an amended complaint against Novartis Gene Therapies, Inc., Novartis Pharmaceuticals ...

SAN FRANCISCO (MarketWatch) -- Genzyme Corp. said Wednesday a motion for a preliminary injunction to delay its proposed acquisition of Bioenvision Inc. has been withdrawn in the Delaware Court of ...

Sanofi-Aventis agreed to buy Genzyme Corp., ending a nine-month pursuit of the U.S. biotechnology company with a sweetened offer of at least $20.1 billion that gives France's biggest drugmaker ...

BOSTON (Reuters) - U.S. biotechnology company Genzyme Corp said on Monday it agreed to sell its genetic testing business to Laboratory Corp of America Holdings for $925 million in cash. Genzyme, which ...

No articles found. Genzyme Corporation did not contribute to any primary research papers from Nature Index journals in the current 12 month window. The following affiliated institutions are wholly ...

Cambridge-based biotechnology firm Genzyme announced the purchase of $23 million in stock from Alnylam Pharmaceuticals Inc. Biotech giant Genzyme has bought a 12-percent stake in Cambridge-based ...

BOSTON, Sept 13 (Reuters) - U.S. biotechnology company Genzyme Corp said on Monday it agreed to sell its genetic testing business to Laboratory Corp of America Holdings for $925 million in cash. Sign ...